Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease
Hk. Kim et al., Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease, CARDIOLOGY, 93(1-2), 2000, pp. 31-36
Citations number
30
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background: Several studies have shown that thrombosis and inflammation pla
y an important role in the pathogenesis of coronary artery disease (CAD). T
issue factor (TF) is responsible for the thrombogenicity of the atheroscler
otic plaque and plays a key in triggering thrombin generation. The aim of t
his study was to assess the levels of TF and tissue factor pathway inhibito
r (TFPI) in patients with angiographically documented CAD and also to evalu
ate TF induction on monocytes in vitro in the presence of these plasmas fro
m patients with CAD. Methods: Plasma antigen levels of soluble TF and TFPI
were measured in 65 CAD patients and 22 healthy controls. Surface TF expres
sion on monocytes from a healthy donor treated with plasma samples was eval
uated by flow cytometry with a direct double-color immunofluorescence techn
ique. Results: Significantly elevated levels of both TF and TFPI were found
in CAD patients compared with healthy controls (303.6 +/- 134.1 vs. 187.3
+/- 108.7 pg/ml, p < 0.05; 85.2 +/- 48.6 vs. 65.0 +/- 29.0 ng/ml, p < 0.05)
. By flow cytometry, monocytes from a healthy donor displayed higher TF ant
igen expression when incubated in the presence of CAD plasmas than in contr
ol plasmas (34.6 +/- 10.7 vs. 23.2 +/- 10.2%, p < 0.05). Conclusions:The hi
gh levels of circulating TF are present in CAD, which were not sufficiently
inhibited by the elevated TFPI plasma levels. Although the source of circu
lating TF is unclear, TF induction of monocytes by plasma from CAD patients
may contribute to the hypercoagulable state. Copyright (C) 2000 S. Karger
AG, Basel.